IBDEI05A ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6800,1,4,0)
 ;;=4^369.9
 ;;^UTILITY(U,$J,358.3,6800,2)
 ;;=^126769
 ;;^UTILITY(U,$J,358.3,6801,0)
 ;;=377.61^^51^454^20
 ;;^UTILITY(U,$J,358.3,6801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6801,1,3,0)
 ;;=3^D/O Pathways w/ Neoplasm
 ;;^UTILITY(U,$J,358.3,6801,1,4,0)
 ;;=4^377.61
 ;;^UTILITY(U,$J,358.3,6801,2)
 ;;=^269241
 ;;^UTILITY(U,$J,358.3,6802,0)
 ;;=379.02^^51^454^68
 ;;^UTILITY(U,$J,358.3,6802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6802,1,3,0)
 ;;=3^Nodular Episcleritis
 ;;^UTILITY(U,$J,358.3,6802,1,4,0)
 ;;=4^379.02
 ;;^UTILITY(U,$J,358.3,6802,2)
 ;;=^269285
 ;;^UTILITY(U,$J,358.3,6803,0)
 ;;=379.07^^51^454^89
 ;;^UTILITY(U,$J,358.3,6803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6803,1,3,0)
 ;;=3^Posterior Scleritis
 ;;^UTILITY(U,$J,358.3,6803,1,4,0)
 ;;=4^379.07
 ;;^UTILITY(U,$J,358.3,6803,2)
 ;;=^269295
 ;;^UTILITY(U,$J,358.3,6804,0)
 ;;=379.92^^51^454^105
 ;;^UTILITY(U,$J,358.3,6804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6804,1,3,0)
 ;;=3^Swelling/Mass of Eye
 ;;^UTILITY(U,$J,358.3,6804,1,4,0)
 ;;=4^379.92
 ;;^UTILITY(U,$J,358.3,6804,2)
 ;;=^269334
 ;;^UTILITY(U,$J,358.3,6805,0)
 ;;=379.93^^51^454^93
 ;;^UTILITY(U,$J,358.3,6805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6805,1,3,0)
 ;;=3^Redness/Discharge of Eye
 ;;^UTILITY(U,$J,358.3,6805,1,4,0)
 ;;=4^379.93
 ;;^UTILITY(U,$J,358.3,6805,2)
 ;;=^104154
 ;;^UTILITY(U,$J,358.3,6806,0)
 ;;=379.99^^51^454^85
 ;;^UTILITY(U,$J,358.3,6806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6806,1,3,0)
 ;;=3^Oth Ill-Defined Eye D/O
 ;;^UTILITY(U,$J,358.3,6806,1,4,0)
 ;;=4^379.99
 ;;^UTILITY(U,$J,358.3,6806,2)
 ;;=^269335
 ;;^UTILITY(U,$J,358.3,6807,0)
 ;;=555.9^^51^454^94
 ;;^UTILITY(U,$J,358.3,6807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6807,1,3,0)
 ;;=3^Regional Enteritis,Unspec
 ;;^UTILITY(U,$J,358.3,6807,1,4,0)
 ;;=4^555.9
 ;;^UTILITY(U,$J,358.3,6807,2)
 ;;=^29356
 ;;^UTILITY(U,$J,358.3,6808,0)
 ;;=696.1^^51^454^92
 ;;^UTILITY(U,$J,358.3,6808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6808,1,3,0)
 ;;=3^Psoriasis
 ;;^UTILITY(U,$J,358.3,6808,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,6808,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,6809,0)
 ;;=709.2^^51^454^39
 ;;^UTILITY(U,$J,358.3,6809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6809,1,3,0)
 ;;=3^Facial Scar
 ;;^UTILITY(U,$J,358.3,6809,1,4,0)
 ;;=4^709.2
 ;;^UTILITY(U,$J,358.3,6809,2)
 ;;=^108131
 ;;^UTILITY(U,$J,358.3,6810,0)
 ;;=710.0^^51^454^60
 ;;^UTILITY(U,$J,358.3,6810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6810,1,3,0)
 ;;=3^Lupus,Systemic Erythmatosis
 ;;^UTILITY(U,$J,358.3,6810,1,4,0)
 ;;=4^710.0
 ;;^UTILITY(U,$J,358.3,6810,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,6811,0)
 ;;=710.9^^51^454^10
 ;;^UTILITY(U,$J,358.3,6811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6811,1,3,0)
 ;;=3^Collagen Disease NOS
 ;;^UTILITY(U,$J,358.3,6811,1,4,0)
 ;;=4^710.9
 ;;^UTILITY(U,$J,358.3,6811,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,6812,0)
 ;;=714.0^^51^454^97
 ;;^UTILITY(U,$J,358.3,6812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6812,1,3,0)
 ;;=3^Rheumatoid Arthritis
 ;;^UTILITY(U,$J,358.3,6812,1,4,0)
 ;;=4^714.0
 ;;^UTILITY(U,$J,358.3,6812,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,6813,0)
 ;;=714.30^^51^454^98
 ;;^UTILITY(U,$J,358.3,6813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6813,1,3,0)
 ;;=3^Rheumatoid Arthritis,Juvenile
 ;;^UTILITY(U,$J,358.3,6813,1,4,0)
 ;;=4^714.30
 ;;^UTILITY(U,$J,358.3,6813,2)
 ;;=^24424
 ;;^UTILITY(U,$J,358.3,6814,0)
 ;;=744.89^^51^454^38
 ;;^UTILITY(U,$J,358.3,6814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6814,1,3,0)
 ;;=3^Face/Neck Anom NEC,Congenital
 ;;^UTILITY(U,$J,358.3,6814,1,4,0)
 ;;=4^744.89
 ;;^UTILITY(U,$J,358.3,6814,2)
 ;;=^272875
 ;;^UTILITY(U,$J,358.3,6815,0)
 ;;=759.6^^51^454^115
 ;;^UTILITY(U,$J,358.3,6815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6815,1,3,0)
 ;;=3^Von-Hippel Lindau Disease
 ;;^UTILITY(U,$J,358.3,6815,1,4,0)
 ;;=4^759.6
 ;;^UTILITY(U,$J,358.3,6815,2)
 ;;=^87431
 ;;^UTILITY(U,$J,358.3,6816,0)
 ;;=759.82^^51^454^62
 ;;^UTILITY(U,$J,358.3,6816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6816,1,3,0)
 ;;=3^Marfan Syndrome
 ;;^UTILITY(U,$J,358.3,6816,1,4,0)
 ;;=4^759.82
 ;;^UTILITY(U,$J,358.3,6816,2)
 ;;=^74034
 ;;^UTILITY(U,$J,358.3,6817,0)
 ;;=802.4^^51^454^36
 ;;^UTILITY(U,$J,358.3,6817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6817,1,3,0)
 ;;=3^FX Malar/Maxillary Bones,Closed
 ;;^UTILITY(U,$J,358.3,6817,1,4,0)
 ;;=4^802.4
 ;;^UTILITY(U,$J,358.3,6817,2)
 ;;=^25312
 ;;^UTILITY(U,$J,358.3,6818,0)
 ;;=870.1^^51^454^53
 ;;^UTILITY(U,$J,358.3,6818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6818,1,3,0)
 ;;=3^Laceration Full Thickness
 ;;^UTILITY(U,$J,358.3,6818,1,4,0)
 ;;=4^870.1
 ;;^UTILITY(U,$J,358.3,6818,2)
 ;;=^274880
 ;;^UTILITY(U,$J,358.3,6819,0)
 ;;=870.2^^51^454^34
 ;;^UTILITY(U,$J,358.3,6819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6819,1,3,0)
 ;;=3^Eyelid Laceration Involving Lacrimal
 ;;^UTILITY(U,$J,358.3,6819,1,4,0)
 ;;=4^870.2
 ;;^UTILITY(U,$J,358.3,6819,2)
 ;;=^274881
 ;;^UTILITY(U,$J,358.3,6820,0)
 ;;=870.3^^51^454^83
 ;;^UTILITY(U,$J,358.3,6820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6820,1,3,0)
 ;;=3^Orbital Wound,Penetrating
 ;;^UTILITY(U,$J,358.3,6820,1,4,0)
 ;;=4^870.3
 ;;^UTILITY(U,$J,358.3,6820,2)
 ;;=^274882
 ;;^UTILITY(U,$J,358.3,6821,0)
 ;;=870.9^^51^454^69
 ;;^UTILITY(U,$J,358.3,6821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6821,1,3,0)
 ;;=3^Ocular Adnexa Open Wound,Unspec
 ;;^UTILITY(U,$J,358.3,6821,1,4,0)
 ;;=4^870.9
 ;;^UTILITY(U,$J,358.3,6821,2)
 ;;=^274885
 ;;^UTILITY(U,$J,358.3,6822,0)
 ;;=871.0^^51^454^70
 ;;^UTILITY(U,$J,358.3,6822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6822,1,3,0)
 ;;=3^Ocular Laceration
 ;;^UTILITY(U,$J,358.3,6822,1,4,0)
 ;;=4^871.0
 ;;^UTILITY(U,$J,358.3,6822,2)
 ;;=^274886
 ;;^UTILITY(U,$J,358.3,6823,0)
 ;;=871.1^^51^454^71
 ;;^UTILITY(U,$J,358.3,6823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6823,1,3,0)
 ;;=3^Ocular Laceration w/ Prolapse
 ;;^UTILITY(U,$J,358.3,6823,1,4,0)
 ;;=4^871.1
 ;;^UTILITY(U,$J,358.3,6823,2)
 ;;=^274887
 ;;^UTILITY(U,$J,358.3,6824,0)
 ;;=871.2^^51^454^99
 ;;^UTILITY(U,$J,358.3,6824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6824,1,3,0)
 ;;=3^Rupture Eye,Trauma Enuc
 ;;^UTILITY(U,$J,358.3,6824,1,4,0)
 ;;=4^871.2
 ;;^UTILITY(U,$J,358.3,6824,2)
 ;;=^274888
 ;;^UTILITY(U,$J,358.3,6825,0)
 ;;=871.6^^51^454^59
 ;;^UTILITY(U,$J,358.3,6825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6825,1,3,0)
 ;;=3^Lens,Penetration w/ FB
 ;;^UTILITY(U,$J,358.3,6825,1,4,0)
 ;;=4^871.6
 ;;^UTILITY(U,$J,358.3,6825,2)
 ;;=^274891
 ;;^UTILITY(U,$J,358.3,6826,0)
 ;;=871.7^^51^454^72
 ;;^UTILITY(U,$J,358.3,6826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6826,1,3,0)
 ;;=3^Ocular Penetration,Unspec
 ;;^UTILITY(U,$J,358.3,6826,1,4,0)
 ;;=4^871.7
 ;;^UTILITY(U,$J,358.3,6826,2)
 ;;=^274892
 ;;^UTILITY(U,$J,358.3,6827,0)
 ;;=871.9^^51^454^9
 ;;^UTILITY(U,$J,358.3,6827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6827,1,3,0)
 ;;=3^Ciliary Body,Open Wound
 ;;^UTILITY(U,$J,358.3,6827,1,4,0)
 ;;=4^871.9
 ;;^UTILITY(U,$J,358.3,6827,2)
 ;;=^274893
 ;;^UTILITY(U,$J,358.3,6828,0)
 ;;=907.2^^51^454^56
 ;;^UTILITY(U,$J,358.3,6828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6828,1,3,0)
 ;;=3^Late Eff Spinal Cord Injury
 ;;^UTILITY(U,$J,358.3,6828,1,4,0)
 ;;=4^907.2
 ;;^UTILITY(U,$J,358.3,6828,2)
 ;;=^275240
 ;;^UTILITY(U,$J,358.3,6829,0)
 ;;=909.5^^51^454^57
 ;;^UTILITY(U,$J,358.3,6829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6829,1,3,0)
 ;;=3^Late or Adverse Effect of Drug
 ;;^UTILITY(U,$J,358.3,6829,1,4,0)
 ;;=4^909.5
 ;;^UTILITY(U,$J,358.3,6829,2)
 ;;=^303353
 ;;^UTILITY(U,$J,358.3,6830,0)
 ;;=918.0^^51^454^104
 ;;^UTILITY(U,$J,358.3,6830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6830,1,3,0)
 ;;=3^Superfic Inj,Eyelids/Periocular
 ;;^UTILITY(U,$J,358.3,6830,1,4,0)
 ;;=4^918.0
 ;;^UTILITY(U,$J,358.3,6830,2)
 ;;=^275352
 ;;^UTILITY(U,$J,358.3,6831,0)
 ;;=918.2^^51^454^103
 ;;^UTILITY(U,$J,358.3,6831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6831,1,3,0)
 ;;=3^Superfic Inj,Conjunctiva
 ;;^UTILITY(U,$J,358.3,6831,1,4,0)
 ;;=4^918.2
 ;;^UTILITY(U,$J,358.3,6831,2)
 ;;=^275353
 ;;^UTILITY(U,$J,358.3,6832,0)
 ;;=921.3^^51^454^111
 ;;^UTILITY(U,$J,358.3,6832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6832,1,3,0)
 ;;=3^Traumatic Hyphemia
 ;;^UTILITY(U,$J,358.3,6832,1,4,0)
 ;;=4^921.3
 ;;^UTILITY(U,$J,358.3,6832,2)
 ;;=^275369
 ;;^UTILITY(U,$J,358.3,6833,0)
 ;;=930.1^^51^454^14
 ;;^UTILITY(U,$J,358.3,6833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6833,1,3,0)
 ;;=3^Conjunctival Sac,Foreign Body
 ;;^UTILITY(U,$J,358.3,6833,1,4,0)
 ;;=4^930.1
 ;;^UTILITY(U,$J,358.3,6833,2)
 ;;=^275486
 ;;^UTILITY(U,$J,358.3,6834,0)
 ;;=930.8^^51^454^33
 ;;^UTILITY(U,$J,358.3,6834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6834,1,3,0)
 ;;=3^Eye,Oth/Combined Sites,Foreign Body
 ;;^UTILITY(U,$J,358.3,6834,1,4,0)
 ;;=4^930.8
 ;;^UTILITY(U,$J,358.3,6834,2)
 ;;=^275488
 ;;^UTILITY(U,$J,358.3,6835,0)
 ;;=940.0^^51^454^8
 ;;^UTILITY(U,$J,358.3,6835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6835,1,3,0)
 ;;=3^Chemical Burn,Periocular
 ;;^UTILITY(U,$J,358.3,6835,1,4,0)
 ;;=4^940.0
 ;;^UTILITY(U,$J,358.3,6835,2)
 ;;=^275512
 ;;^UTILITY(U,$J,358.3,6836,0)
 ;;=940.1^^51^454^35
 ;;^UTILITY(U,$J,358.3,6836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6836,1,3,0)
 ;;=3^Eyelid,Burns
 ;;^UTILITY(U,$J,358.3,6836,1,4,0)
 ;;=4^940.1
 ;;^UTILITY(U,$J,358.3,6836,2)
 ;;=^275513
 ;;^UTILITY(U,$J,358.3,6837,0)
 ;;=940.2^^51^454^18
 ;;^UTILITY(U,$J,358.3,6837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6837,1,3,0)
 ;;=3^Cornea/Conj,Alkaline Burn
 ;;^UTILITY(U,$J,358.3,6837,1,4,0)
 ;;=4^940.2
 ;;^UTILITY(U,$J,358.3,6837,2)
 ;;=^275514
 ;;^UTILITY(U,$J,358.3,6838,0)
 ;;=940.3^^51^454^17
 ;;^UTILITY(U,$J,358.3,6838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6838,1,3,0)
 ;;=3^Cornea/Conj,Acid Burn
